|
Vitiligo y
Fototerapia
Vitíligo
El Vitíligo es caracterizado por
perdida de pigmento en parches en el cuerpo. El Vitíligo provee poca incomodidad
física, pero muchas veces es muy estresante. Los científicos creen que el
vitíligo puede ser in proceso autoinmune en el cual el cuerpo destruye su propio
pigmento.
Tratamiento de Luz Ultravioleta
para Vitíligo
El tratamiento de luz Ultravioleta, o
fototerapia para vitíligo puede ayudar a crear re pigmentación. Este proceso es
lento, trabajando de los bordes exteriores de cada parche hacia adentro, así que
se receta tratamiento regular de fototerapia para el vitíligo. El tratamiento
de fototerapia para vitíligo puede continuar dos veces a la semana por un año o
más. Se recetan luces Ultravioleta B de banda angosta principalmente. Ver la
investigación de fototerapia
Ultravioleta- vitíligo
Equipo de Fototerapia en el Hogar para
tratar vitíligo
Los tratamientos para Vitíligo en su hogar o en la oficina de su doctor es una
decisión entre usted y su doctor. El equipo de fototerapia está basado en el
tamaño del área afectada por el vitíligo. Las unidades de fototerapia usadas
más frecuentemente para vitíligo son FOLDALITE,
PANOSOL, Y
DERMALIGHT.
|
#1
Narrow-band Ultraviolet B is a Useful and Well-Tolerated Treatment for Vitiligo Lubomira Scherschun, MD; Jane J. Kim, MD; Henry W. Lim, MD. Journal of American Academy of Dermatology. VOL 44, Number 6. June 2001 |
|
Seven diverse vitiligo patients treated for one year with narrow-band UVB therapy. Five of the seven achieved 75% repigmentation with a mean of 19 treatments.
CONCLUSION:
Treatment protocol resulted in rapid repigmentation in many patients, including those with skin phototypes IV and V. In accordance with previous studies, this report indicates that narrow-band UVB is a useful and well-tolerated therapy for vitiligo.
|
 |
|
#2
Treatment of Generalized Vitiligo in Children with Narrow-Band (TL-01) UVB Radiation Therapy. M. D. Njoo, MD, PhD and W. Westerhof, MD, PhD. Journal of American Academy of Dermatology. Vol 42, Number 2, Part 1. February 2000
|
|
Studied efficacy and safety of UVB (311 nm) therapy in children with generalized vitiligo. 51 Children were treated twice a week for one year. Psychosocial impact of disease and treatment were carefully evaluated before and after. 75% overall repigmentation in 53% of patients and a stabilization of the disease in 80%.
CONCLUSION:
Narrow-band UVB therapy is effective and safe in childhood vitiligo; it may also significantly improve the quality of life.
|
|
|
#3
Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Samson Yashar S. Photodermatology, Photoimmunology & Photomedicine [Photodermatol Photoimmunol Photomed], 2003 Aug; Vol. 19 (4), pp. 164-8; PMID: 12925186 |
|
BACKGROUND:
Narrow-band ultraviolet B (NB-UVB) therapy has been used successfully for the treatment of inflammatory and pigmentary skin disorders including atopic dermatitis, psoriasis, mycosis fungoides, polymorphous light eruption, and vitiligo. METHODS: This is a retrospective review of the treatment outcomes of 117 consecutive patients with vitiligo, pruritus, and other inflammatory dermatoses, excluding those with psoriasis and CTCL, who were treated with NB-UVB between 1998 and 2001 at our institution. RESULTS: Approximately 80% of all patients showed improvement in their condition. NB-UVB phototherapy was well tolerated, with no serious adverse effects. In patients with vitiligo, 6.4% had an abnormal thyroid-stimulating hormone level and 6.5% had anemia.
CONCLUSION:
NB-UVB may be considered as a viable therapeutic option in the treatment of vitiligo, pruritus, and other inflammatory dermatoses. Long-term adverse effects and cost-benefit analysis of NB-UVB therapy compared to other treatment modalities remain to be determined.
|
|
